Published on 30 May 2024 on Investing.com
Insmed stock target lifted on positive trial results By Investing.com
On Wednesday, Wells Fargo maintained an Overweight rating on shares of Insmed (NASDAQ:INSM) ...
NASDAQ.INSM price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free